RICHARD RAMIREZ: Open Payments
NPI 1528598570 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 34 payments from 9 companies in 2025. Trend: 2023 $528 · 2024 $553 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 9 | $422 |
| Gilead Sciences, Inc. | 11 | $382 |
| ABBVIE INC. | 4 | $70 |
| Indivior Inc. | 3 | $66 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Alkermes, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: CABENUVA, Yeztugo, APRETUDE, SUBLOCADE, VRAYLAR, Biktarvy, CAPLYTA, PIFELTRO.
Industry payments across HI — which companies pay providers there.
